Bux Pain Management announced the successful implementation of the SynchroMed III intrathecal drug delivery system. This new solution is designed to help patients suffering from chronic pain, cancer pain, and severe spasticity. The U.S. Food and Drug Administration (FDA) approved this innovative technology on October 10, 2023, which represents a significant advancement in pain management therapy.
The SynchroMed III system by Medtronic is setting a new standard in patient care. This next-generation pump builds on over three decades of pain pump relief by introducing enhanced safety, efficiency, and effectiveness to pain management. It features a “refill only” workflow and updatable firmware post-implantation, marking significant advancements in the delivery of medication directly to the spinal fluid to target the source of pain.
Dr. Anjum Bux, a seasoned pain management specialist with 18 years of experience, has been at the forefront of this medical breakthrough. Having implanted approximately 500 intrathecal pain pumps, Dr. Bux continues to lead the way in innovative treatments. On December 13, 2023, he became one of the first physicians in the country to implant the SynchroMed III pump. The first recipient in Kentucky has reported life-changing improvements, regaining the ability to engage in cherished activities with loved ones such as playing with his grandchildren and enjoying activities that he couldn’t do before.
“The SynchroMed III pump represents a monumental leap forward in our ability to manage chronic pain for patients,” said Dr. Anjum Bux. “By delivering medication directly to the pain’s source, we can significantly improve the quality of life for our patients with minimal side effects. It’s truly gratifying to see such positive outcomes and to know we are making a real difference.”
Amidst the ongoing battle against opioid abuse and misuse, the SynchroMed III system emerges as a safe and effective alternative. It offers precise control over medication delivery with minimal side effects, and is compatible with 1.5T and 3T full-body MRI scans, ensuring comprehensive diagnostic capabilities.
Dr. Bux has successfully implanted 20 SynchroMed III pumps and manages approximately 700 pain pumps. He is committed to enhancing the quality of life for those with chronic neck or low back pain, especially for those who have exhausted other treatment options.
